Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> GLAXOSMITHKLINE Latest News

SEP 16, 2014 - Zero Hedge

A Must Read - Share

China Stocks Tumble Most In Six Months; US Futures Lower As Key Risk Events Loom

If over the weekend we got some terrible economic news out of China, then overnight it was turn for a major disappointment in capital flows, when Chinese Foreign Direct Investment in August crashed by 14%, far below the 0.8% increase expected, attracting just $7.2 billion in FDI, and the lowest in four years. This once again sparked fears of a ...

Tags: China Stocks Tumble Most In Six Months; US Futures Lower As Key Risk Events Loom,  Glaxosmithkline Latest News

SEP 15, 2014 - Benzinga

A Must Read - Share

SEP 12, 2014 - Zero Hedge

A Must Read - Share

Credit Suisse Warns Of "Self-Fueling Negative Feedback" In Scotland; Here's Who Is Exposed

While we noted earlier the dramatic outflows and record selling in stocks in UK, Credit Suisse warns, it could get much worse... The flow diagram below explains how the uncertainty over Scotland's currency and ability to backstop its financial sector can set in train a self-fuelling feedback loop of rising risks and costs to the Scottish financial and sovereign sectors, ...

Tags: Credit Suisse Warns Of "Self-Fueling Negative Feedback" In Scotland; Here's Who Is Exposed,  Glaxosmithkline Latest News

SEP 12, 2014 - TheStreet

A Must Read - Share

Trading Guidelines for J&J, Merck, Pfizer, 8 Other Drug Companies

NEW YORK (TheStreet) --aInvestors have so many choices when allocating cash to pharmaceutical stocks that making prudent decisions can be difficult. But there are ways to cut through the clutter, if investorsaconsider the numbers. Read more:a4 Stocks Warren Buffett Is Selling in 2014 There are 11 pharmaceutical stocks with market capitalizations above $50 billion.aThree are components of the Dow Jones ...

Tags: Trading Guidelines for J&J, Merck, Pfizer, 8 Other Drug Companies,  Glaxosmithkline Latest News

SEP 09, 2014 - Zacks Investment Research

A Must Read - Share

Glaxo (GSK) Updates on Asthma Candidate Mepolizumab - Analyst Blog

GlaxoSmithKline announced positive data from two pivotal phase III studies on its asthma candidate, mepolizumab.

Tags: Glaxo (GSK) Updates on Asthma Candidate Mepolizumab - Analyst Blog,  Glaxosmithkline Latest News